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Abstract 
Huntington’s disease (HD) is a debilitating neurodegenerative disease that is part 
of a class of diseases affecting the basal ganglia, a group of subcortical structures in the 
brain. Impaired negative emotion recognition is a common and early symptom of HD, 
and entails the patient being unable to properly identify negative emotions on human 
faces. Through analysis of cell label patterns in a macaque cortex with a retrograde tracer, 
a region in the ventromedial striatum has been identified with the potential to function as 
a critical hub in the emotion processing networks. This region of the striatum receives 
projections from cortical and subcortical regions involved with emotion processing, 
including the amygdala, ventromedial prefrontal cortex, orbitofrontal cortex, anterior 
cingulate cortex, and temporal lobe. Analysis of the region of the striatum receiving the 
projections above will be evaluated to provide more insight into the link between the 
progression of the pathophysiology of HD and the symptoms of HD over time. The 
identification of this hub has the potential to broaden our understanding of 
symptomatology and progression in HD, contribute to other projects in neuropsychiatric 
disorders involving the striatum, and provide further data for the study of brain 
connectivity as a whole. 
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1. Introduction 
 Despite many years of dedicated study, the primate brain and its inner workings 
have proven difficult for researchers to understand. Connectome and projects like it focus 
on using modern advances in neuroimaging and other technologies to provide more 
information about the ways that primate brains take in and process information and put 
out behavior. These projects use different methodologies and approaches to gain more 
insight into the primate brain. Some study the behaviors directly, attempting to elicit 
specific behaviors in controlled environments. Others study the biochemistry of neurons 
and glia, attempting to understand more about the very basic functions that sustain and 
change the brain as an organ. Others focus on a middle ground between these extremely 
small-scale and large-scale approaches, the physical structures of the brain. 
Neuroanatomy, the study of these structures, is an on-going project with the eventual goal 
of mapping the location and nature of all functional and physical structures in the brain 
and their connections.  
 Studying NHP (see Figure 1 for explanations of abbreviations) anatomy has led to 
great insights regarding human neuroanatomy. In turn, these insights have led to further 
discoveries in other translational fields. Mapping the physical connectivity of brain 
regions can strengthen theories about particular networks and systems. However, these 
physical data are difficult to collect in humans. By studying the pathology and 
symptomology of certain diseases in humans allows researchers are able to access 
information about the connections between human anatomy and behavior. Through the 
coinciding study of HD and the basal ganglia, much has been revealed regarding the 
relationship between human anatomy and behavior. In the following project, I discuss the 
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implications that increasing knowledge regarding connectivity in the primate basal 
ganglia might have for the future study of HD.  
 
1.1 The primate basal ganglia 
 The basal ganglia are a set of deep-seated subcortical nuclei comprising the 
striatum, nucleus accumbens, globus pallidus, subthalamic nucleus, and substantia nigra 
(Haber & Gdowski, 2004). Traditionally, the basal ganglia have been associated with 
motor control, due to the clear motor symptomatology of movement disorders such as 
Parkinson’s Disease and Huntington’s Disease, both of which include neuropathology of 
the striatum (Haber & Gdowski, 2004). However, it has become increasingly clear 
through further research that the basal ganglia perform an integrative function in the 
brain, connecting cognitive, motor, and limbic systems (Haber & Gdowski, 2004).  
1.1.1 Function 
 In environments and with brains that provide near infinite possibilities for actions, 
the basal ganglia serve as an ‘option-picker,’ adding the filter of experience and habit to 
behavioral choices (Haber & Gdowski, 2004). These nuclei have long been identified as 
processes involved in coordinating movement and in the reward-guided learning circuit 
(Neubert et al, 2015; Haber et al, 2006; Jarbo & Verstynen, 2015). 
The basal ganglia are most famous for their role in coordinated movement. A 
class of neurodegenerative disorders, including Parkinson’s disease and Huntington’s 
disease, primarily affect the nuclei of the basal ganglia. They are classified as movement 
disorders because of the obvious motor symptoms that accompany the progression of the 
disease. Research investigating the exact function of the basal ganglia in motor behavior 
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has shown that the functions are wide-ranging (Haber & Gdowski, 2004).  Early studies 
showed that the basal ganglia primarily returned projections to the motor cortex (Nauta & 
Mehler, 1966). However, it was eventually determined that basal ganglia nuclei are also 
responsible for properly timing movements (Denny-Brown, 1962; Kornhuber, 1974; 
MacLean, 1978), proper motor planning, and the integration of sensory and motor 
networks (Marshall et al., 1971; Teuber, 1976; Marsden, 1984; Evarts et al., 1985; 
Lidsky et al., 1985; Marsden, 1985).  
 The basal ganglia were identified as key nuclei in the reward-guided learning—or 
reinforcement learning—circuit in the mid-20th century. However, it was later determined 
that the striatum is most functionally relevant for reinforcement learning (Graybiel, 
1995). The ventral striatum was originally considered to be the more critical region for 
reinforcement learning. However, more recent studies provide evidence that regions 
outside of the ventral striatum, including the dorsomedial caudate, are also involved in 
reinforcement learning (Jarbo & Verstynen, 2015). Further, regions of the striatum have 
been identified as a possible substrate for direct overlap between executive controls and 
reward signals (Haber & Knutson, 2010; Haber et al., 2006). This involvement in 
reinforcement has implicated the striatum in the pathology of addiction. Finally, striatal 
involvement in the development of addiction supports the theory that the striatum is 
critically involved in habit formation and reinforcement learning, as well as in integrating 
affective signals (Everitt & Robbins, 2005; Everitt, 2015).  
1.1.2 Major nuclei 
 The striatum is the nucleus of the basal ganglia that receives cortical, thalamic, 
and brain stem input. The striatum consists of the caudate nucleus and putamen, 
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structures that are separated by bundles of the internal capsule.  The nucleus accumbens 
and the ventral most portions of the caudate and putamen form the ventral striatum. The 
striatum projects to the globus pallidus and the nucleus accumbens projects to the 
substantia nigra. These connections and the striatum will be discussed in greater detail in 
sections 1.1.3 and 1.2, respectively.  
 Haber and Gdowski (2004) discuss the major basal ganglia nuclei in their chapter 
in The Human Nervous System. The first major nucleus, the globus pallidus—or 
pallidum—lies medial to and is capped by the putamen. The pallidum has an external and 
an internal segment. The external segment of the pallidum is a key process in the indirect 
cortico-basal ganglia-cortical loop, as seen in Figure 2 and described in section 1.1.3. 
Meanwhile, the internal segment of the pallidum is a process in the direct loop. 
Regardless of location in the internal or external segment, all pallidal neurons are 
GABAergic. The process as a whole serves a relay station between the striatum and the 
thalamus. The external segment projects to the subthalamic nucleus, and the external 
segment projects to the ventrolateral thalamic nucleus and the ventral anterior thalamic 
nucleus.  
 The subthalamic nucleus is located medial to the internal capsule and stretches 
posterior to rest above the rostral substantia nigra. This nucleus is a key process in the 
indirect loop, providing excitatory input to the internal segment of the globus pallidus. 
The STN receives GABAergic input from the pallidum, glutamatergic input from the 
cortex, and some minor afferent projections from other basal ganglia structures. Axons 
from neurons in the STN all bifurcate and project both to the pallidum and the substantia 
nigra.  
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 The substantia nigra can be found dorsal to the cerebral peduncle, and is separated 
into the pars reticulata and pars compacta on the basis of differing chemical anatomy. 
Although the need for further subdivision in primates has been suggested, the pars 
reticulate typically refers to any neurons not belonging to the clearly identifiable pars 
compacta. The substantia nigra projects to and receives projections from the striatum, 
which form the striato-nigro-striatal loops involved in drug addiction, reinforcement 
learning, and habit formation (Haber et al., 2000).   
1.1.3 Connectivity 
 The basal ganglia are organized in two major cortico-basal ganglia-thalamo-
cortical loops, as depicted in Figure 2. Haber and Gdowski (2004) describe these 
pathways as well. The direct pathway carries signals from the cortex through the 
striatum, the internal segment of the globus pallidus and the thalamus to excite the cortex. 
The indirect pathway passes through the striatum and into the external segment of the 
pallidum and then the subthalamic nucleus before passing through the thalamus to inhibit 
the cortex. Within this gross structure, there are also smaller loops, including the spiraling 
striato-nigro-striatal pathway (Haber et al., 2000).  
The direct loop is shown in Figure 2 and is comprised of the cortex, striatum, 
internal segment of the pallidum, and thalamus. The medium spiny neurons of the 
striatum receive glutamatergic inputs from the cortex. These neurons are classified as D1 
due to the presence and type of dopamine receptors.  The D1 neurons of the striatum 
project to the pallidum and provide inhibitory, GABAergic input. This inhibits the 
tonically firing, inhibitory pallidal neurons that project to the thalamus. This transient 
inhibition of tonic inhibition causes the thalamus to transiently excite the cortex, which 
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closes the loop.  
The indirect loop has the exact opposite effect on the cortex. By involving the 
external segment of the globus pallidus and the subthalamic nucleus, the indirect loop 
produces net inhibition of the cortex. In this loop, D2 neurons of the striatum project onto 
and transiently inhibit the external segment of the pallidum. The neurons of the external 
segment tonically inhibit the subthalamic nucleus, which transiently excites the internal 
segment of the pallidum. Recall, the internal segment tonically inhibits the thalamus. By 
transiently exciting internal segment neurons, the subthalamic nucleus further inhibits the 
thalamus, which inhibits the cortex. It is important to note that in the study of both the 
direct and indirect pathways, researchers have primarily focused on motor systems. In 
more recent years, studies have been dedicated to applying this model to cognitive and 
affective functions with success. However, the body of evidence is still focused on motor 
function of the basal ganglia.  
 
1.2 The primate striatum 
 The striatum is a particularly critical process of the basal ganglia, which can be 
inferred based on its position in the cortico-basal ganglia-cortical loops, seen in Figure 2. 
Studies that focus on subjects with injuries to the striatum find that widespread 
behavioral changes result from the injuries. In a seminal meta-analysis published in 1994, 
Kailash Bhatia and C. David Marsden found that injuries to the caudate and/or putamen 
in humans—typically due to stroke, hypoxia, or, occasionally, toxic damage—caused 
motor disorders in addition to a variety of cognitive or behavioral disorders, including 
confusion, abulia, disinhibition, obsessive-compulsive, speech disorders, depression, and 
		 10	
memory disturbances. However, these disorders were specific to the site of damage.  
Putaminal damage more often resulted in motor disorders, while damage to the caudate 
resulted in behavioral disorders. This functional specificity of the nuclei fits the current 
understanding of the connectivity of the caudate and putamen (Haber & Gdowski, 2004). 
Furthermore, the wide variety of these disorders support the conclusion that the striatum 
as a whole receives projections from almost all cerebral regions.  
The caudate nucleus is an elongated, ovular nucleus that stretches along the lateral 
ventricle before looping back and terminating near the rostral end (Haber & Gdowski, 
2004). The main region of gray matter located rostrally and dorsomedial to the putamen 
is referred to as the head of the caudate. Sections of the caudate further caudal to the head 
are called the body. The remaining small and ventral regions of the caudate are called the 
tail of the caudate. These sections of the caudate are labeled on a 3-D model in Figure 3. 
The caudate receives projections from much of the cerebral cortex, especially the frontal 
cortex (Haber, 2016). These anatomical results support the functional and clinical 
conclusions that the caudate is critical for integrating executive control and reinforcement 
with other systems. In humans with specific damage to the caudate, there is a high 
prevalence of cognitive and behavioral disorders including abulia, disinhibition, speech 
disorders, and depression (Bhatia & Marsden, 1994).  
The putamen is the nucleus of the striatum that lies ventrolateral to the caudate 
nucleus and is a rounded, rather egg-shaped structure, as depicted in Figure 3. Almost all 
projections to the striatum from the motor and pre-motor regions terminate in the 
putamen (Haber & Gdowski, 2004). Additionally, the putamen receives input from the 
amygdala and several other limbic structures (Haber, 2016; Haber & Gdowski, 2004). 
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This connectivity matches functional data that show an association between the putamen 
and motor functioning. In a meta-analysis of lesions to the lentiform nucleus—the 
putamen and globus pallidus—humans showed extensive motor symptoms, including 
chorea, dystonia, and parkinsonism (Bhatia & Marsden, 1994).  
The ventral striatum includes the nucleus accumbens and ventral portions of the 
caudate and putamen. This region of the striatum is strongly associated with habit 
formation and reinforcement learning (Haber, 2011). The ventral striatum receives input 
from the cerebral cortex, thalamus, and midbrain dopaminergic cells. These projections 
terminate in overlapping topographies. Efferent projections from the ventral striatum 
terminate in the substantia nigra and globus pallidus (Haber, 2011).  
 
1.3 Convergence in the striatum 
Despite this regional specificity, the striatum as a structure receives extremely 
widespread and diverse input from almost all cortical regions. Neuroanatomists have 
therefore concluded over the course of the past several decades that the striatum has the 
potential to serve as a site of convergence between cognitive, motor, and limbic systems 
by receiving projections from all of these regions. Seminal papers published in the 1970s 
and 1980s first demonstrated the potential for neural convergence in the caudate, and 
work identifying patterns of convergence has since continued, with great success. 
Regions of the striatum have been identified as critical hubs—defined in section 1.3.2—
in a number of networks, including certain symptoms of OCD and visual attention in 
addiction.  
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1.3.1 History 
From the discovery that the striatum received projections from nearly the entire 
cerebral cortex, researchers posited that this convergence of projections must serve some 
purpose. Yeterian & Van Hoesen (1978) identified early patterns of overlap in the 
striatum, followed by Selemon & Goldman-Rakic (1985) who started to map these 
topographies. These first discoveries identified a pattern of convergence in which cortical 
regions that have corticocortical connections also tend to project to similar regions of the 
striatum. This pattern has continued to be supported by the evidence as research has 
continued. These seminal studies have given way to a body of work dedicated to the 
identification of regions of especially high convergence in the striatum. These studies 
have identified potential anatomical substrates for symptoms of addiction and OCD, as 
well as reward-based learning and motivation (Calzavara et al., 2014; Choi et al., 2017; 
Haber & Knutson, 2010; Haber et al., 2006). These regions of high convergence are 
referred to as critical hubs, a term that comes from the application of network theory to 
neuroscience.  
1.3.2 Critical hubs 
 Network theory is a mathematical theory used to understand systems and their 
interactions. When applied to neuroscience, and specifically structural neuroscience, 
network theory maps brain systems as graphs with nodes and edges—where nodes are 
brain areas or regions and edges are the connections between these areas (van den Heuvel 
& Sporns, 2013). These nodes interact with one another via the edges, i.e. brain regions 
interact with other regions via the axonal projections between them. Nodes can be 
characterized in many different ways. Of particular interest to this project are connector 
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or critical hubs. Critical hubs have a high degree of diverse connection and must receive 
and put out connections to many regions of the brain that are in different systems (van 
den Heuvel & Sporns, 2013). These hubs serve as a connection point between different 
brain systems. These characterizations can be made based on functional or structural data. 
In this project, the data collected is structural, meaning the potential hub identified is 
structural as well. The application of network theory has been instrumental for furthering 
the understanding of complex brain systems and system interactions. Although brain 
regions and areas appear to have a certain degree of functional specificity, viewing the 
brain as a series of functionally specific units does not explain most of the phenomena the 
brain can produce (van den Heuvel & Sporns, 2013).  
 Some of these inexplicable phenomena include widespread deficits seen in 
neuropsychiatric disease (Albin et al., 1989). Several disorders specifically affect the 
striatum and other nuclei of the basal ganglia. Drug addiction, Parkinson’s disease, and 
HD all affect the cells of the striatum. HD is of particular interest because of its unique 
pathology—medium spiny neurons of the striatum are selectively killed. This makes HD 
a useful model for studying striatal connectivity in humans. By identifying particular 
symptoms of HD in humans and studying the neural correlates in the NHP model, regions 
that can potentially serve as critical hubs within the striatum are revealed.  
 
1.4 Huntington’s disease 
Huntington’s Disease (HD) is a devastating neurodegenerative illness that affects 
3 people out of every 100,000 worldwide (Pringsheim et al, 2012). It is classified as a 
movement disorder because of its debilitating and degenerative motor symptoms. 
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However, HD has more recently been shown to have severe cognitive and affective 
symptoms as well (Ha & Fung, 2012). HD’s pathology primarily affects the striatum, a 
region in the basal ganglia (Vonsattel, 1998). For this reason, HD has been used a model 
illness for studying the basal ganglia and striatum in humans.  
Despite its practical function as a model illness, the actual mechanism by which 
the pathophysiology of HD causes the largescale symptomology is not well understood. 
The origins of misfolded proteins and HD’s heritability have been linked to the 
huntingtin gene. Furthermore, much research has been devoted to identifying and 
cataloging changes in volume of certain brain regions over the course of the illness, as 
well as the symptomology of the disease. However, how exactly the expression of the 
huntingtin gene causes the widespread pathology remains a mystery.  
1.4.1 Pathophysiology 
 The genetic cause of HD is well documented. In humans, HD results in 
individuals with 35 or more CAG repeats in the huntingtin gene, located on chromosome 
4 (Zuccato et al., 2010). These repeats are inherited and are considered too severe to 
occur at random. The huntingtin gene codes for glutamine, an amino acid, and the 
aberrant version of the gene codes for a polyglutamine tract causing misfolding of the 
final protein (Ha & Fung, 2012). It is known that the misfolded protein interferes with 
many different cellular functions, incuding axonal trafficking, NMDA receptor 
activation, protein-protein interactions, protein clearing, and gene transcription (Ha & 
Fung, 2012). The mechanisms by which these disruptions produce the neuropathology of 
HD are not understood. However, there are several mechanisms that have been identified 
and are being investigated for their potential use as a treatment site.   
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 The primary mechanism of interest for this project that is currently under 
investigation is the excitotoxicity theory. This hypothesis suggests that selective cell 
death in the striatum is due to excitotoxicity from overactive glutamatergic projections 
from the cortex (Zuccato et al., 2010). The medium spiny neurons of the striatum depend 
on these glutamatergic projections for survival, and in HD, it appears as though there is 
increased release of glutamate into the corticostriatal synapse, as well as decreased 
efficacy of the NMDA receptors on the postsynaptic surface (Zuccato et al., 2010). This 
combination causes the death of the medium spiny neurons, the hallmark of HD. This 
hypothesis is promising, because it explains the breakdown of the corticostriatal synapse, 
as well as the cell death in the striatum. However, it does not explain the whole brain 
atrophy experienced by 80% of HD patients (Vonsattel & DiFiglia, 1998), which makes 
it unlikely that the excitotoxicity hypothesis paints a complete picture of the mechanisms 
in HD.  
Further mechanisms that are more broadly of interest include the loss of BDNF, 
proteolysis, aggregation of the Htt protein, dysfunction of the mitochondria, and 
interruption of proper gene transcription (Zuccato et al., 2010). In patients with HD, there 
is a widespread loss of brain-derived neurotrophic factor (BDNF), a neurotrophic factor 
that supports the survival of neurons around the brain (Zuccato et al., 2010). At this 
point, it is unclear exactly how the aberrant huntingtin protein causes loss of BDNF or 
how the loss of BDNF contributes to the selective cell death seen in HD. However, it has 
been found that the administration of BDNF in models of HD has a neuroprotective effect 
(Zuccato et al., 2010). The toxic fragment hypothesis suggests that the misfolded 
huntingtin protein becomes more neurotoxic when it is lysed in the cells. This view, 
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pioneered and supported by the Hayden group, argues that the lysis of the aberrant 
huntingtin protein allows the polyglutamine tracts to build up within the cell. These tracts 
encourage cellular mechanisms meant to be protective that lead to the eventual death of 
the cell. The aggregation hypothesis suggests neurotoxicity is associated with the 
aggregation of the whole aberrant huntingtin proteins, although the exact mechanism by 
which these aggregates cause cell death is unknown. The huntingtin protein is also known 
to affect mitochondria function by binding directly to the mitochondrion and interrupting 
normal metabolic activity as well as mobility within the cell. Finally, the aberrant 
huntingtin protein can also affect normal gene transcription, preventing normal gene 
expression.  
These mechanisms all describe some piece of the larger mechanistic puzzle. With 
the current understanding of these theories, they provide disparate explanations for the 
neuropathology of HD. However, there is promise of eventual reconciliation of the 
different mechanisms into a singular view of the progression of HD.   
1.4.2 Neuropathology 
 In contrast with the physiological mechanisms, the gross neuropathology of the 
HD is fairly well understood. The hallmarks of HD include whole brain atrophy, 
particularly in the frontal lobes and the striatum (Vonsattel & DiFiglia, 1998). Atrophy is 
also seen in the thalamus, white matter, and the globus pallidus. Atrophy of the striatum 
is particularly severe, occurring in 95% of cases (Vonsattel & DiFiglia, 1998). Given that 
the striatum is the most prominent site of active degeneration, the pattern of atrophy in 
the striatum has been well studied. Medium spiny neurons are selectively killed (Han et 
al., 2010), starting in dorsolateral caudal portion of the striatum and progressing 
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diagonally to the ventromedial rostral portion (Hedreen & Folstein, 1995).  This selective 
cell death preferentially involves the indirect cortico-basal ganglia-cortical loop, causing 
increased cortical excitation.  
1.4.3 Symptomology 
 The neuropathology of HD leads to progressive and debilitating symptoms. The 
severity and progression of symptoms is subject to a number of variables, discussed in 
the next section. However, regardless of when the symptoms occur, they can all be sorted 
into three categories: motor, affective, and cognitive.  
 Motor symptoms of HD can be simply characterized as involuntary and extra 
movements, balanced with increasing dystonia and inability to move voluntarily (Roos, 
2010). In the degeneration of the striatum, the cells that participate in the indirect loop as 
defined above are preferentially killed, causing increased cortical excitation. In terms of 
symptomology, this progression typically begins as chorea—extra, involuntary, repetitive 
movements—in the extremities and the small facial muscles (Roos, 2010). This 
progresses to include difficulty walking and eventually bradykinesia, dysarthria, and 
dysphagia (Roos, 2010). Further, patients typically experience increasing difficulty with 
dynamic balance, mobility, motor performance, and postural control (Ha & Fung, 2012). 
Each patient experiences a unique combination of chorea and hypokinesia, so 
generalizing across patients is difficult (Roos, 2010). However, almost all patients suffer 
the same symptoms in varying degrees. These motor symptoms are well-documented in 
the literature and were the first symptoms of HD studied. In fact, HD was known as 
Huntington’s Chorea until more recently.  
In contrast, affective or behavioral symptoms of HD are not well characterized or 
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understood. Despite the high incidence of behavioral symptoms, they continue to be 
considered a secondary priority in diagnosis and treatment. Up to 20% of clinical HD 
patients experience severe psychiatric disturbances, with many more experiencing more 
mild psychiatric symptoms (Ha & Fung, 2012). These can include suicidal ideation and 
attempts, irritability and aggression, psychosis, and depressive, anxiety, and affective 
disorders (Gray et al., 2012). Clusters of these symptoms show up in meta-analyses of 
patients in the clinical phase and suggest that the symptoms are primary symptoms of HD 
(Rickards et al., 2011). Furthermore, physicians are beginning to call for more rigorous 
inclusion of behavioral measures in the diagnosis process (Nagel et al., 2014). The 
development of accurate behavioral measures and better mapping of symptom 
progression in coming years will likely prove interesting.  
Similarly, cognitive symptoms in HD are still being identified. It is therefore 
much more difficult to concisely describe the host of symptoms a patient with HD will 
experience during the course of their disease. However, most patients will experience 
some combination of the following symptoms: deficits in visuomotor integration, 
psychomotor speed, executive function, and emotion recognition, as well as other 
predominantly frontal lobe deficits (Papoutsi et al., 2014). These cognitive impairments 
typically emerge in the pre-clinical phase (Papoutsi et al., 2014) and mirror the 
preferential involvement of the indirect cortico-basal ganglia-cortical loop described in 
section 1.1. However, these different cognitive functions are difficult to measure even 
within individuals, as changes to cognitive processes exist in the normal aging process. 
Furthermore, certain cognitive functions that are distinctly cortical—and not 
subcortical—in nature are preserved throughout early stages of HD, including semantic 
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memory, language comprehension, and spatial awareness and orientation. All of these 
factors paint a complicated picture of cognitive deterioration in HD. The underlying 
neuroanatomy is missing from this picture, however, motivating the project presented 
here.  
Some cognitive symptoms lend themselves better than others to longitudinal 
study. Deficits in emotion recognition are easily operationalized. Several studies have 
tested individuals with HD over the course of their illnesses to determine cognitive 
decline, and, in particular, decline in the ability to properly identify human emotions 
(Bora et al., 2015; Labuschagne et al., 2013). These studies report changes in emotion 
recognition in pre-manifest patients with HD—meaning they are still in the pre-clinical 
phase. This symptom is interesting for two main reasons. First, the ability to perform 
socially is integral to the human experience, and deficits in emotion recognition can make 
it extremely difficult for patients to interact with other people in professional, personal, 
and social capacities. Second, this emotion recognition symptom tends to emerge earlier 
than motor symptoms, suggesting that the progression of this symptomology is linked to 
the progression of the disease pathology as well. Moreover, early deficits in emotion 
recognition selectively affect negative emotion recognition (Bora et al., 2015). The 
recognition of negative emotions involves networks such as face recognition and emotion 
processing that have been closely examined for many decades, making emotion 
recognition a particularly good model symptom for investigation here.  
 
1.5 Neurobiology of emotion recognition 
 Emotion-face perception or emotion recognition is a complex process distributed 
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across many different regions of the brain. Proper emotion recognition appears to also 
require certain temporal associations, although these temporal associations fall outside of 
the scope of the following project (Vuilleumier & Pourtois, 2007). Across networks, 
regions associated with face recognition, sensory integration and processing, fear, and 
emotion integration and regulation are implicated in emotion recognition (Vuilleumier & 
Pourtois, 2007). All of these regions show enhanced activation when subjects are 
presented with emotional faces, specifically including the amygdala, ACC, vmPFC, OFC 
(including the OMPFC) and FFA (Vuilleumier & Pourtois, 2007). As a result, the 
amygdala, ACC, vmPFC, OFC, and temporal lobe are the cortical targets of this project.  
 The amygdala is famously associated with the fear response. However, more 
recent work has suggested involvement in reward and motivation circuits as well 
(LeDoux, 2007). The amygdala is a nucleated structure in the medial temporal lobe, and 
each nucleus has a unique set of inputs and outputs (LeDoux, 2007). Of particular interest 
for this project are the basal and lateral nuclei of the amygdala, because of their cortical 
connectivity. These nuclei receive input from sensory thalamic and cortical regions, as 
well as prefrontal cortex (LeDoux, 2007). Further, the lateral nucleus projects to the basal 
nucleus, which projects to the ventral striatum (LeDoux, 2007). These connections 
suggest the involvement of the lateral and basal nuclei in a potential critical hub in the 
ventral striatum.  
 The ACC is also involved in emotion recognition and is more generally associated 
with top-down emotion regulation (Etkin et al., 2011). Top-down emotion regulation is 
typically understood as the application of cognitive processes—like attention switching—
to emotion processes. The ACC has been functionally implicated in emotion reappraisal 
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and other emotion distancing tasks (Etkin et al., 2011). Further, the ACC has functional 
connectivity to the amygdala, indicating involvement in negative emotion (Etkin et al., 
2011).  
 Similarly, the vmPFC is also involved in emotion regulation; however, functional 
characterization of the vmPFC is typically very broad (Roy et al., 2012). These 
characterizations include producing and maintaining ‘affect’, regulation, and default-
mode (Roy et al., 2012). Some argue that the vmPFC is itself a site of integration for 
many different processes, including episodic memory, representation of affective 
valences of sensory events, social cognition, and affective behavioral and physiological 
responses (Roy et al., 2012). These descriptions all vary, but they share the premise that 
the vmPFC is somehow involved in emotion processing.  
 Meanwhile, the OFC appears to play an integrative role as well. The OFC has 
anatomical connections to subcortical structures that are involved in emotion, behavior, 
and motivation (An et al., 1998; Öngür et al., 1998; Rempel-Clower & Barbas, 1998). 
Evidence suggests that the OFC integrates decision-making and emotion (Bechara et al., 
2000). The OFC is related specifically to fear circuits and motivation circuits through 
connections to the amygdala, striatum, and thalamus (Öngür & Price, 2000). 
Furthermore, the OFC projects to regions of the diencephalon and brainstem that mediate 
the physiological responses associated with affective states. This pattern of connectivity 
shows that the OFC is clearly involved in integrating the experience of emotions and 
cognition.  
 The final region of particular interest in emotion recognition is the temporal lobe. 
In humans, the FFA is responsible for face recognition and is a region of the fusiform 
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gyrus in the temporal lobe (Kanwisher et al., 1997). This region has perhaps one of the 
strongest functional associations of any region of cortex and is selectively activated by 
visual exposure to faces (Kanwisher et al., 1997). Recent work suggests that the temporal 
lobe is more generally associated with modality-specific and modality-general sensory 
processing, and that these associations are organized in a gradient by connectivity along 
the length of the lobe (Jackson et al., 2017). In human studies, emotion recognition 
involves activation of the FFA. However, NHP temporal lobe anatomy is not identical. 
The macaque species examined in this project do not have a FFA, but rather a series of 
face patches (Tsao et al., 2008). 
 
1.6 The macaque model 
 The advantage of using NHP models for studying neuroanatomy is the highly 
conserved nature of subcortical structures across primate species. However, not all 
structures are conserved, and the frontal lobes in humans are particularly unique. Human 
brains have greater volumes and much larger surface areas than NHP brains, and as a 
result, have greater gyrification (Rilling, 2006). This greater surface area allows further 
parcellation of regions into specific anatomical areas. Furthermore, human brains are not 
simply scaled-up versions of NHP brains (Rilling, 2006). However, especially in the 
regions identified above, there are strong similarities between NHP and human patterns 
of connectivity. The primate basal ganglia are highly conserved (Haber & Gdowski, 
2004), which suggests that results found in the NHP striatum are largely translatable to 
the human striatum. Furthermore, the connectivity of OFC circuits is fairly conserved 
across primate species as well (Öngür & Price, 2000).  
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 The greatest difference between species in the anatomy discussed in this project is 
found in the face recognition system. While fMRI results show activation in the FFA 
when humans view faces, similar studies show activation in a series of face patches in the 
temporal lobe when macaques view faces (Yovel & Freiwald, 2013; Tsao, 2014). These 
face patches vary from animal to animal, although they are typically found in similar 
regions of the temporal lobe (Tsao et al., 2008; Tsao, 2014). As a result of this within 
species variability, it is difficult to identify the face patches without performing live cell 
recordings or fMRI scans on each individual animal. However, three face patches are 
typically found in the anterior portion of the temporal area (Tsao et al., 2008), so for the 
purposes of this project, the focus will be on the anterior temporal regions.  
It would be false to claim either that the regions of the prefrontal cortex examined 
here are identical across species, or that connectivity in the NHP brain exactly maps onto 
connectivity in the human brain. However, by focusing on functional regions that share 
functional associations across species, conclusions drawn from projects working with the 
NHP model can still inform theories regarding human neuroanatomy and connectivity.  
 
1.7 Hypotheses 
 Based on the synthesis of known information regarding the basal ganglia, HD, 
and emotion recognition, there appears to be a gap in the literature where the 
neuroanatomy of emotion recognition should be. The striatum serves as a site of cortical 
integration for many different networks, and it receives projections from many different 
regions involved in emotion recognition. Furthermore, deficits in emotion recognition 
occur in HD, a disease that causes the selective cell death of striatal medium spiny 
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neurons. All of this suggests a potential critical hub in the striatum.  
The project laid out in this paper will primarily address two hypotheses regarding 
critical hubs in the macaque striatum. The first hypothesis is that there exists an 
anatomical substrate underlying the integration of emotion processing and face 
recognition in the ventral striatum. This substrate could serve as a critical hub connecting 
these networks and explaining the breakdown in the related capabilities in patients with 
HD and degeneration of the striatum.  Further, the second hypothesis is that this substrate 
stretches further laterally in the striatum than the currently existing literature suggests, 
which explains the early occurrence of these symptoms in the progression of HD.  
 
2. Methods 
The first step for identifying a potential critical hub in any region of brain 
involves a retrograde analysis. This analysis requires the injection of a retrograde tracer 
into the region of interest, which will be taken up by any axon terminals in the region and 
transported back to the cell body. The cell bodies containing the tracer are labelled during 
a staining procedure, and they are identified and counted by a researcher viewing serial 
sections of the brain under a light microscope. The number of cells per standard 
anatomical area will quantify the strength of the connection, while the density of cell 
label can be used to qualify the connection as strong or weak. These qualifications can be 
used to compare relative strengths of connection between different areas and regions.  
 
2.1 Project structure 
In this project, six cases with retrograde tracer injections into different regions of 
the striatum were compared. All six cases showed cell label in the cortex, however, the 
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specific areas of cortex and distribution of the cells differed based on the placement of 
the injections within the striatum. The striatal regions with the strongest cell label in the 
regions of interest are the most likely to serve as a critical hub in the emotion processing 
network. In the case of these specific hypotheses, it is possible that more than one case or 
small region of the striatum could be involved in the hub. Figure 4 shows the location of 
the injections from each of the six cases within the macaque striatum. 
 
2.1 Tissue preparation 
All procedures listed in this section and section 2.2 are reported by Calzavara et al 
(2014). The six cases analyzed here were six adult, male macaques, of the following 
species: 1 Macaca mulatta, 2 Macaca fascicularis, and 3 Macaca nemestrina. All 
procedures, including those not outlined explicitly here, were approved by the University 
of Rochester Committee on Animal Resources and adhere to the ILAR Guide for the 
Care and Use of Laboratory Animals. All macaques received surgical procedures for the 
placement of tracers and sacrifice. The injection placement procedures were performed 
under sterile operating conditions while the animals were anesthetized with Ketamine, 
delivered intramuscularly at 10 mg/kg. Proper levels of anesthetization were maintained 
via isoflurane throughout the procedure.   
Predetermined injection sites were mapped in two different ways. In older cases, 
physiological recording was used to locate the striatal injection sites. For these cases, 
macaques received intravenous pentobarbital at 20 mg/kg. In any newer cases, the 
injection sites were mapped using MRI imaging performed on the macaques in the days 
leading up to the procedure.  
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Throughout all procedures, temperature, heart rate, and respiration were 
monitored constantly. Macaques were placed in a stereotaxic apparatus from David Kopf 
Instruments and the surgeon performed a midline incision, with muscles and fascia 
displaced laterally. A craniotomy was then made over the region of interest and small 
dural incisions were made at the injection sites. All cases analyzed here were of either 
retrograde or bidirectional tracers-- wheat germ agglutinin (WGA), fluorescein (FS), or 
Lucifer Yellow (LY)-- which were placed via pressure injection over 10 minutes, with 
the syringe then left in situ for an additional 10-20 minutes.  
After the injection placement, the macaques survived approximately 14 days in 
the vivarium with close monitoring of behavior, health, and surgical wounds, until the 
sacrifice. The macaques were anesthetized with Ketamine again, followed by 
pentobarbital. They were then transcardially perfused with saline followed by a 4% 
paraformaldehyde and 1.5% sucrose solution in 0.1M, pH 7.4. The brains were removed 
from the skull cavity and postfixed overnight. The brains were then cryoprotected in 
increasing gradients of sucrose solution.  
The brains were cut into serial sections at 50 microns depth on a freezing 
microtome. Sections were sorted out so that staining procedures would be run on first one 
in 24 sections, then one in 8 sections per tracer. Immunhistochemistry procedures were 
performed on free-floating tissue sections. They were first treated with 10% methanol 
and 3% hydrogen peroxide (0.1M PB to inhibit endogenous peroxidase activity). They 
were then rinsed for 1-2 hours in 0.1M PB with 0.3% Triton X-100 solution (TX). The 
tissue sections were finally preincubated in 10% normal goat serum (NGS) and 0.3% TX.  
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After preincubation, tissue sections were incubated in primary anti-WGA, anti-
FS, or anti-LY in 10% NGS. The immunoreactivity was visualized using a standard DAB 
(3,3’-diaminobenzidine tetrahydrochloride) procedure. The staining was then intensified 
by incubating the tissue in 0.05% DAB, 0.025% cobalt chloride, 0.02% nickel 
ammonium sulphate and 0.01% hydrogen peroxide for 1-15 minutes. After the IHC 
staining protocols, tissue sections were mounted onto gel-coated slides, dehydrated, 
defatted in xylenes, and coverslipped with Permount. 
Once the slides were prepared and ready for analysis, the boundaries of injections 
were mapped using counterstained or adjacent Nissl-stained slices and standard 
anatomical classifications (Walker, 1940; Matelli et al., 1985, 1991; Paxinos et al., 
2000). Cases with white matter or cortical contamination at the injection site were 
excluded from analysis, as well as cases missing pieces of cortical tissue.  
 
2.2 Data collection 
Labelled cortical cells were charted using StereoInvestigator under 4X and 10X 
objectives of a light microscope. They were marked using an optical fractionator guide to 
focus the eye and minimize distractions in order to achieve the most accurate count of 
cells. The cortex was segmented into the anatomical areas using standard anatomical 
classifications, and the boundaries of each area constrained the optical fractionator. Cells 
were marked by researchers trained to identify cell bodies with the particular staining 
protocols used here. These determinations were based on size, shape, color, and 
granulation and were made in bright field. The amygdalar nuclei were segmented using 
counterstained or adjacent Nissl-stained sections and the standard anatomical 
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classifications. The boundaries of the nuclei were then used to constrain the optical 
fractionator that was used for counting cells.  
The contours and cell markers created in StereoInvestigator were transferred to 
Adobe Illustrator and modified in size, color, and thickness for ease of comparison. These 
contours were laid out next to one another in Figures 6, 7, and 8 as presented below. 
Patterns and density of cell label are compared across the different cases. Patterns of cell 
label refer to the areas and visual appearance of the cell label at the level visible with a 
macroscope. The density of cell label is used to determine the strength of identified 
connections. The assumption in these cases is that the greater the number of projecting 
neurons, the stronger the functional connection between locations in the brain. Density of 
cell label, then, is determined to be either dense or light.  This determination is made by 
eye after training to do so. Figure 5 provides examples of both dense and light cell label.  
 
3. Results 
All injection sites received input from the prefrontal cortex, although with varying 
degrees of strength and different patterns of cell label. Only the ventromedial and 
ventrolateral striatal cases received projections from the amygdala. The control cases—
MF170FS, MF170LY, and MN39WGA—all received inputs from different regions of the 
prefrontal cortex, while none received input from the amygdala. These preliminary 
results show that the ventromedial and ventrolateral striatum are uniquely connected to 
the cortical regions of interest investigated in this project. 
 
 
		 29	
3.1 Projections to the ventromedial striatum 
Two of the six cases received injections to the ventromedial striatum, MR13WGA 
and MN33WGA. These injections included the nucleus accumbens, as well as the 
caudate nucleus. As seen in Figure 6, these cases had cell label in the vmPFC, OFC, and 
ACC. In MR13WGA, there was clearly dense cell label. MN33WGA had lighter cell 
label in the regions of interest. However, this case also had lighter cell label throughout 
the cortex, which indicates the difference in label density could be due to poor uptake of 
the tracer in the striatum. One particular difference between the two cases can be found in 
the ACC. MR13WGA has particularly strong label in the ACC in relation to 
MN33WGA. Nevertheless, clear and similar patterns of cell label are found in the PFC of 
these two cases. 
As seen in Figure 7, these two cases also had cell label in the basolateral nuclei of the 
amygdala. The cell label in the amygdala of MR13WGA is more dense. In both cases, 
there are clear projections from the amygdala to the ventromedial striatum. Other nuclei 
of the amygdala also show cell label.  
Figure 8 shows patterns of cell label from the temporal lobe of MR13WGA. Due to 
tissue damage, data from the temporal lobe in MN33WGA were excluded. The cell label 
in the temporal lobe in MR13WGA is light, despite the strength of cell label in the PFC, 
indicating weaker projections from the temporal lobe to the striatum. Although the 
macaque face patches of the temporal lobe cannot be properly identified without further 
examination, the cell label in this case appears to be in the region of the temporal lobe 
where the face patches are typically found.  
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3.2 Projections to the ventrolateral striatum 
One case, MN40LY, received an injection to the ventrolateral striatum. This injection 
also appears to include parts of the nucleus accumbens and caudate nucleus, in addition 
to the rostral putamen. As seen in Figure 6, there are projections from many regions of 
the PFC to this region of the striatum. Unlike the first two cases, there is also cell label in 
the dorsal PFC of this case, due to the putaminal involvement. Additionally, the patterns 
of cell label in the vmPFC and OFC of MN40LY are different from both ventromedial 
striatal cases. There is diffuse or sparse label throughout the OFC, vmPFC, and ACC of 
this case.  
Figure 7 shows very dense label throughout the entire amygdala, indicating very 
strong projections to the ventrolateral striatum. The strength of this connection is 
especially clear in comparison with the ventromedial striatal cases.  
This region of the striatum also receives clear input from the temporal lobe, as seen in 
Figure 8. The label in this case is very densely distributed throughout the entire rostral 
portion of the temporal lobe, again indicating potential involvement of the face patches.  
 
3.3 Projections to other regions of striatum 
The other three cases included in this paper received injections to the dorsal caudate, 
putamen, and ventral putamen. These cases all saw different patterns of cell label. The 
dorsal caudate and dorsal putamen cases had dense cell label in the dorsal PFC, in stark 
contrast with the other four cases. Two of these cases, the dorsal caudate and putamen 
injections, had much more dense label in the ACC than all other cases, as well as the 
most dense label in the dorsal PFC. The third case, the ventral putamen injection, showed 
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the most sparse PFC label of all cases, likely due to its caudal location in the putamen. 
All of these difference in cell label pattern is clearly visible in Figure 6.  
No temporal lobe data were collected for these cases due to incomplete tissue and 
time constraints. Additionally, there were no cell bodies found in the amygdala of these 
three cases either. As a result, they are not included in Figure 7 or Figure 8.  
 
4. Discussion 
 This project has yielded several important insights. First, there is the potential for 
convergence of projections from regions involved in face and emotion processing in the 
ventral striatum. Second, this convergence could serve as a substrate for the breakdown 
of emotion recognition in HD. Third, further analysis of these results and further 
investigation is necessary for drawing strong conclusions.  
 
4.1 Potential convergence in the ventral striatum 
 The results of this analysis indicate the potential for convergence in the ventral 
striatum. As discussed in the section 3, the ventral striatum in the six cases examined here 
received projections from the vmPFC, OFC, ACC, temporal lobe, and amygdala. 
Moreover, the potential region of convergence seems larger than what would be expected 
based on previous studies of corticostriatal circuitry (Haber, 2016). Based on the cell 
label patterns here, the potential critical hub could stretch most of the rostral ventral 
striatum. Further investigation is necessary to confirm this pattern, as discussed in section 
4.5.  
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4.2 Strength of results 
 The prefrontal cell label was collected by another member of the Haber lab 
several years ago as part of a larger retrograde striatal connectivity study (Tanimura & 
Haber, unpublished). The amygdala cell label was collected as part of this project. In both 
cases, cells were rigorously counted. Further, the anatomical areas of interest in both 
these regions are well separated in the literature and easily mapped onto the cases at 
hand. For this reason, the patterns of cell label presented here are strong evidence of 
projections from the regions of interest.  
The label in the temporal cortex is the weakest set of data in this project. While 
cell label in the temporal lobe is certainly promising, the macaque face patches are 
notoriously difficult to locate in individual macaques, which typically must be done 
through electrophysiology. As a result, these patterns of cell label in the temporal lobe 
shown in the macaques included in this study do not conclusively show involvement of 
the face patches in the critical hub. However, involvement of the temporal lobe at all is 
important. First, this shows involvement of more caudal regions of cortex, which is 
discussed further in section 4.3. Second, the temporal lobe is typically functionally 
associated with complex and abstract sensory processing. When integrated with emotion 
processing networks regardless of the specific sensory modality, this kind of sensory and 
emotion processing hub has the potential to explain symptoms in HD including deficits in 
emotion recognition as well as other cognitive symptoms (Bora et al., 2015).  
 
4.3 Implications for Huntington’s disease 
 The results presented here provide a compelling explanation for the progression 
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of cognitive symptoms in HD that is currently lacking. The field has not reached a 
consensus regarding the specific physiological nature of these symptoms. Competing 
theories attribute changes in emotion recognition either to changes in parietal and 
occipital regions responsible for visual processing, or damage to the temporal regions 
responsible for face recognition (Papoutsi et al., 2014).  Here, we suggest a third 
possibility—these changes in emotion recognition are due to the same subcortical 
physiological changes causing the motor symptoms. Until recently, the striatum has 
typically been characterized as receiving strong projections from the frontal lobes. While 
this characterization is certainly fair given the overwhelming strength of those 
projections, it paints an incomplete picture of striatal connectivity. In more recent years, 
researchers have started investigating the projections from caudal regions of cortex to the 
striatum (Choi et al., 2017). These investigations have yielded important insights 
regarding the striatum’s role as a site of integration. Without this complete picture of 
corticostriatal circuitry, it is reasonable to assume that the etiology of symptoms like 
deficits in emotion recognition must lie in the cortex. However, given the evidence 
presented here and in other recent studies, subcortical etiology of symptoms like emotion 
recognition should be considered.  
Furthermore, a hub in the ventral striatum serving as the substrate for the deficit 
in emotion recognition answers questions regarding the time course of HD that cortical 
etiology does not. Striatal etiology could explain the early emergence of this cognitive 
symptom. Cortical degeneration typically occurs well into the clinical phase of HD 
(Kassubeck et al., 2004). However, striatal degeneration begins decades before the onset 
of the clinical phase (Vonsattel & DiFiglia, 1998).  
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Ultimately, the product of this project is to inform further investigation. As 
discussed in Section 1.4, cognitive and affective symptoms of HD are not well studied or 
understood. A more complex and holistic understanding of the anatomy affected by HD 
can help researchers create a more complete picture of the disease and its progression. 
Moreover, a better understanding of the anatomy can lead to new avenues for treatment 
by providing new targets for translational researchers to investigate.  
 
4.4 Limitations of the project 
 This project was limited in its scope and power by time and methodology. Some 
of these limitations can be improved through further study, as discussed in section 4.5, 
however, other limitations are inherent to the neuroanatomical methodology employed 
here.  
4.4.1 Normal neuroanatomy 
 In this study, only healthy adult male macaques were examined. For this reason, 
the implications for disease models are obviously limited. No conclusions can be drawn 
from this study regarding the progression of HD or its symptoms. Furthermore, it is not 
possible to test potential treatment methods. However, by understanding the location and 
strength of normal, healthy connections in the functioning primate brain, we can reveal 
information that can guide the study of HD animal models, producing more disease-
specific results.  
4.4.2 Variation across species 
 Although much can be learned from studying non-human primate neuroanatomy, 
there are obvious differences across species. This is a problem for this project in several 
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ways. First, HD appears to be a largely human disease. Animal models of the disease do 
exist, however, the primary motivation for study is developing treatment for human 
patients. Second, the regions of cortex examined in the course of this project are regions 
that are largely variable across species. In section 1.6, the specific details of this 
variability are discussed. As a result of these differences, all comparisons between NHP 
and human anatomy must be read carefully. Fortunately, the basal ganglia and the general 
patterns of connection have been shown to be highly conserved across primate species, 
allowing for a fair amount of confidence in the cross species applicability of the results of 
this kind of project (Haber & Knutson, 2010).    
4.4.3 Microcircuitry 
 Importantly, these types of neuroanatomical studies do not reveal any details 
regarding the specific microcircuitry of the striatum. Conclusions regarding convergence 
in the region require the assumption that the microcircuitry is complex and integrated; i.e. 
that cells receiving projections within the striatum are connected to one another, as well 
as to nearby cells receiving projections from other regions of cortex. This assumption has 
been generally shown to be true [add citation here for paper about micro]. However, 
nothing about the specific microcircuitry that is relevant in the ventral striatum is 
revealed during the course of this project. Therefore, it is impossible to strongly conclude 
that a critical hub does in fact exist in this region of striatum. Rather, this region of 
striatum may potentially serve as an anatomical substrate for convergence of the emotion 
processing and face recognition networks.  
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4.5 Future directions 
 The first step in continuing this project will be conducting the stereological count 
of cortical cells. Some of the cell counts have been completed, especially in the prefrontal 
cortex, however, there are not complete cell counts for each region of interest. By 
counting the cells using stereological techniques, the density of cell label in a particular 
anatomical area can be reconstructed and quantified in 3D. This would quantify the 
connection strength from regions with cell label to the ventral striatum, allowing for 
statistical analysis.  
Furthermore, the results of this project have indicated that an anterograde study 
should be completed in order to fully comprehend the convergence of projections in the 
striatum. The retrograde tracer study on its own cannot produce sufficient evidence that a 
critical hub indeed exists in the ventral striatum, nor can it provide any details regarding 
the quality of the hub. However, the results can indicate a potential substrate for network 
integration. In order to determine the degree of overlap in the projection areas, in addition 
to the size, shape, and location of the specific topographies from each target cortical 
region, anterograde tracer studies must be conducted.  
Such a study would involve the injection of anterograde tracers in regions of the 
vmPFC, OFC, amygdala, and temporal lobe. Tracer would be taken up by cell bodies in 
these regions and transported down the axon to the terminal bouttons. These labeled 
terminals would create terminal fields in the striatum, which could be marked, collected, 
and overlaid with terminal fields of other cases to create a heat map of projection from 
the cortical regions of interest to the ventral striatum.  
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5. Conclusion 
 Guided by the deficits in emotion recognition experienced by patients with HD, 
this project has provided evidence for a potential anatomical substrate for integration of 
the emotion processing and face recognition networks necessary for proper emotion 
recognition in the ventral striatum of the macaque. Further study should include 
stereological analysis and anterograde anatomical, electrophysiological, and disease 
model studies.  
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Figure Legends 
 
Figure 1 
 This table contains the abbreviations used in this manuscript and their meanings, 
listed in alphabetical order.   
 
Figure 2 
 This figure from Neuroscience (2008) depicts the major basal ganglia nuclei and 
their connectivity. The figure shows the indirect cortico-striato-cortical loop (in beige) 
and the direct cortico-striato-cortical loop.  
 
Figure 3 
 This figure shows a 3-D representation of the right hemisphere of a macaque 
cortex, as well as a macaque striatum removed and to the left. The striatum is labeled 
with the caudate and putamen to illustrate the size, shape, and location of the nuclei in 
relation to the rest of the cortex.  
  
Figure 4 
 This figure shows 3-D representations of the injection sites from all six cases 
merged onto a digital global model of the macaque striatum, showing different views. 
Each color corresponds to a particular case. Blue- MR13WGA; Teal- MN33WGA; 
Green- MN40LY; Yellow- MF170FS; Goldenrod- MF170LY; and Orange- MN39WGA. 
(A) The lateral view reveals the rostral-caudal and dorsal-ventral spread of the different 
injections. (B) The rostral view shows the medial-lateral spread of injections on a coronal 
section. (C) The dorsal view shows the medial-lateral and rostral-caudal spread. 
 
Figure 5 
 These photomicrographs show the difference between regions with dense cell 
label and light cell label. What constitutes dense versus light cell label differs from region 
to region and between tracers, therefore the exact standard is determined and agreed upon 
by neuroanatomists on a case by case basis. (A-D) Are photomicrographs showing cell 
label in the following regions: (A) dense cell label in the vmPFC; (B) light or patchy cell 
label in the vlPFC; (C) dense cell label in the amygdala; (D) light cell label in the 
amygdala.  
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Figure 6 
 This figure shows a selection of coronal cross sections from the frontal lobes of 
all six cases. The columns have cross sections that are roughly equivalent in their rostral-
caudal location. Rows have cross sections from the case noted in the leftmost column. 
Major regions of the frontal lobes are labeled in the top row. The injection sites of the 
first three cases comprise the target region in the striatum. The next three cases are 
controls.  
  
Figure 7 
 Similar to Figure 6, this figure shows the patterns of cell label in the amygdala of 
the cases comprising the target region of the striatum. All three cases had significant cell 
label in the amygdala. The three control cases had no cell label in the amygdala and are 
therefore excluded.  
 
Figure 8 
 This figure is the final results figure, and it shows the pattern of cell label in the 
temporal lobe of two of the target cases. The third case was excluded due to extensive 
tissue damage. Notably, the more lateral injection in MN40LY shows significantly 
greater cell label in the temporal lobe.  
 
 
 
 
 
 
 
 
 
 
		 40	
Figures 
Figure 1 
 
Abbreviation Meaning 
ACC anterior cingulate cortex 
BDNF brain derived neurotrophic factor 
CAG cytosine, adenine, guanine-- the unit of base pairs repeated in aberrant huntingtin gene 
D1 striatal medium spiny neurons, expressing D1-type dopamine receptors 
D2 striatal medium spiny neurons, expressing D2-type dopamine receptors 
DAB 3,3’-diaminobenzidine tetrahydrochloride 
dPFC dorsal prefrontal cortex 
FFA fusiform face area 
FS Fluorscein 
GABA gamma-aminobutyric acid, a neurotransmitter 
GPe globus pallidus, external segment 
GPi globus pallidus, internal segment 
HD Huntington's disease 
Htt Huntingtin 
ILAR Institute for Laboratory Animal Research 
LY Lucifer Yellow 
MRI magnetic resonance imaging 
NGS normal goat serum 
NHP non-human primate 
NMDA receptor glutamate receptor, named for its agonist N-methyl-D-aspartic acid 
OCD obsessive compulsive disorder 
OFC orbitofrontal cortex 
OMPFC orbitomedial prefrontal cortex 
PB phosphate buffer 
PFC prefrontal cortex 
SN substantia nigra 
STN subthalamic nucleus 
vmPFC ventromedial prefrontal cortex 
WGA wheat germ agglutinin  
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